HYCAMTIN
NDC 0078-0674, topotecan hydrochloride, injection, powder, lyophilized, for solution, from Novartis Pharmaceuticals Corporation.
- Product NDC
- 0078-0674
- Status
- Listed
- Labeler
- Novartis Pharmaceuticals Corporation
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020671
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0674 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPOTECAN HYDROCHLORIDE4 mg/4mL
Pharmacologic classes
Topoisomerase Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0078-0674-61 | 00078067461 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0078-0674-61) / 4 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/eeee060c-a9ec-423e-a374-8484009f8524
Use it
Look up 0078-0674 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0078-0674 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0078-0674. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.